Gain Therapeutics's top three insider shareholders as of August 04, 2026 are Eric I Richman (Chief Executive Officer, 289.63K shares), Eric I Richman (Chief Executive Officer, 217.73K shares), Khalid Islam (Executive Chairman, 50.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Eric I Richman | Chief Executive Officer | 289,629 | 0 | 01 Jul, 2024 |
| Matthias Alder | Chief Executive Officer | 21,140 | 0 | 28 Mar, 2024 |
| Jeffrey Scott Riley | - | 30,000 | 0 | 01 Apr, 2024 |
| Khalid Islam | Executive Chairman | 50,000 | 0 | 12 Aug, 2024 |
| Gene Mack | Cfo And Interim Ceo | 14,400 | 0 | 12 Aug, 2024 |
| Salvatore Calabrese | Chief Financial Officer | 3,000 | 0 | 23 May, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 24 Mar, 2026 | Gene Mack | Employee Stock Option (right to buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 24 Mar, 2026 | Gianluca Fuggetta | Employee Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 24 Jun, 2025 | Jeffrey Scott Riley | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Eric I Richman | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Dov A Md Goldstein | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Gwen A Melincoff | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Claude Nicaise | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Khalid Islam | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Eric I Richman | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Hans Peter Hasler | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 24 Jun, 2025 | Eric I Richman | Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 20 Mar, 2025 | Gianluca Fuggetta | Employee Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 20 Mar, 2025 | Gene Mack | Employee Stock Option (right to buy) | A | 200,000 | $0.00 | 200,000 | D | A |
| 06 Jan, 2025 | Gene Mack | Stock Option (right to buy) | A | 271,325 | $0.00 | 271,325 | D | A |
| 09 Aug, 2024 | Gene Mack | Common Stock | A | 14,400 | $1.01 | 14,400 | D | P |
| 09 Aug, 2024 | Khalid Islam | Common Stock | A | 50,000 | $1.00 | 50,000 | D | P |
| 01 Jul, 2024 | Eric I Richman | Common Stock | A | 5,000 | $1.23 | 277,629 | D | P |
| 01 Jul, 2024 | Eric I Richman | Common Stock | A | 5,000 | $1.23 | 277,629 | D | P |
| 01 Jul, 2024 | Eric I Richman | Common Stock | A | 5,000 | $1.23 | 277,629 | D | P |
| 01 Jul, 2024 | Eric I Richman | Common Stock | A | 12,000 | $1.21 | 289,629 | D | P |